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A b s t r a c t  
A new UV spectrophotometric method was developed for quantitative evalution of 
Olmesartan medoxomil preparations. The UV detector was set at 256nm. Beers law is 
obeyed in the concentration range of 2.0 -14.0 øg/ml. The method was found to be 
selective, linear, accurate and precise in the specified ranges. Intra and interday variability 
for the method were < 2% relative standard deviation common excipients used as 
additives in pharmaceutical preparations do not interfere with the proposed method. This 
method was successfully used for quantification of Olmesartan medoxomil in pure form 
and in pharmaceutical preparations. 
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Introduction 
Olmesartan medoxomil (OLM) is a prodrug. It is hydrolyzed to 
Olmesartan during absorption from the gastrointestinal tract [1ă3]. 
Olmesartan is a selectiveAT1 subtype angiotensin II receptor 
antagonist. OLM is described chemically as 2, 3-dihydroxy-2-
butenyl4-(1-hydroxy-1-methylethyl)-2-propyl-1-[p-(o-1Htetrazol-
5ylphenyl) benzyl] imidazole -5-carboxylate, cyclic 2,3-carbonate 
[4]. There is no reference for determination of this drug in both 
bulk and dosage forms in official compendia. A literature survey 
reveals that several methods were reported for the estimation of 
OLM in plasma, serum and tablets by liquid chromatography.[5-
7].The use of LC hyphenated techniques for identification of 
degradation products in stressed tablets of OLM was published 
in.[8] OLM has been determined in biological fluids using LC 
coupled to fluorescence and tandem mass spectrometry[9-11]. 
There are also reports on capillary electrophoresis for the 
quantitative determination of this drug in coated tablets.[12] 
However, only one UV spectrophotometric  method is reported for 
the analysis of OLM in pharmaceutical dosage forms [13]. 
Therefore, it is a necessity to develop a new and simple method. 
Therefore, in the proposed work, a successful attempt has been  
 
 
 
 
 
made to develop analytical method with due consideration of 
accuracy, sensitivity, rapidity, economy. 
Experimental 
Instrumentation 
A JASCO  UV- Vis spectrophotometer  630 with matched quartz 
cells of 1cm optical path length was used for spectrophotometric 
measurements were performed at 20μ0.1 0C. 
Materials and Reagents 
All chemicals used were of analytical grade. OLM reference 
substances (99.9%) were kindly provided by Cipla Pharmaceutical 
Ltd, Mumbai, India and the commercially available tablets were 
purchased from local market. 
Determination of λmax  
Weighed amount of OLM was dissolved in methanol: water 
(10:90) to obtain a 100 øg/ml stock solution. Absorption maxima 
was studied by diluting the above solution to 20 øg/ml and scaned 
from 200- 400 nm 
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Standard stock solutions of OLM (reference 
substance)  
Prepared by dissolving 10mg OLM reference substance in 
methanol 10mg and volume was made up with distilled water in a 
100ml volumetric flask (100 øg/ml). 
Linearity and calibration 
The aliquots standard stock solution was diluted serially with 
water to obtain the concentration range of 2.0-14.0 øg/ml. A 
calibration curve for OLM was obtained by measuring the 
absorbance at the λmax 257nm. Statistical parameters like the 
slope, intercept, co-efficient of correlation, BeerÊs law, Molar 
Absorptivity, SandellÊs sensitivity were determined.  
Assay 
Twenty tablets of OLM were weighed; average weight was 
determined and powdered in glass mortar. Amount equivalent to 
10 mg of OLM was transferred to 100ml volumetric flask, 
dissolved in 10ml of methanol, sonicated and made up the volume 
with distilled water to obtain a concentration of 100 øg/ml. This 
solution was then filtered through whatmann filter paper no.41. 
From this filtrate, 2ml was withdrawn and transferred to 10ml 
volumetric flask, volume was adjusted to the mark and 
absorbance was recorded against distilled water as a blank at 257 
nm (Table -2) 
Accuracy 
To assess the accuracy of the proposed method, recovery studies 
were carried out at three different levels i.e. 80%, 100%and 
120%.To the preanalysed sample solution a known amount of 
standard drug solution was added at three different levels, 
absorbance was recorded. The % recovery was then calculated 
as % Recovery = [(A-B)/C]ï100, where A is total amount of drug 
estimated; B is amount of drug found on preanalysed basis; C is 
amount of pure drug added to formulation( Table-3)  
Precision 
Precision of the method is studied as repeatability, intra-day and 
inter-day precision. Repeatability was determined by analyzing 
OLM (8øg/ml) for six times (Table 4).Intra- day precision was 
determined by analyzing the 6,8 and10 øg/ml of OLM  for three 
times in the same day. Inter-day precision was determined by 
analyzing the same concentration of the solutions daily for three 
days (Table 5). In intermediate precision study, % RSD values 
were not more than 2% in all the cases.  
Ruggedness 
Ruggedness of the proposed method is determined by analysis of 
aliquots from homogeneous slot by two analyst using same 
operational and environmental conditions    (Table 6) 
Limit of detection and Limit of quantitation 
Limit of detection (LOD) and Limit of quantitation (LOQ) were 
determined by using the formula based on standard deviation of 
the response and the slope. Limit of detection (LOD) and limit of 
quantitation (LOQ) were calculated by using the equations LOD = 
3ïĔ/S and LOQ= 10ïĔ/S, where Ĕ is standard deviation of intercept, 
S is slope of the line.  (Table 1)   
Results and discussion 
The absorption spectrum of the final solution exhibits an 
absorption peak at 256nm (figure2).linearity of the method was 
observed in the expected concentration the range of 2.0-14.0 
øg/ml. Stastical analysis of the calibration curve was done and the 
results are summarized in (Fig 3). The correlation co-efficient (r2 = 
0.9998) shows the validity of beers law. The proposed method 
was applied to pharmaceutical formulation and percent amount of 
drug estimated was found in good agreement with the label claim. 
The excipients used in the pharmaceutical preparation do not 
interfere in this analysis. The recovery experiment was carried out 
at three different levels i.e., 80%, 100% and 120%. The 
percentage recovery was found to be in the range 99.9-100.1; the 
low values of % RSD are indicative of accuracy and reproducibility 
of the method .The precision of the method was studied as an 
intra-day and inter-day and repeatability. Ruggedness of the 
proposed method was studied with the help of two analyst. 
Repeatability f the samples also carried out which show low 
values of % RSD. The limits of Detection and Quantification for 
OLM with a lower concentration were 0.193 and 0.640øg/ml 
respectively, values which are under the lowest expected 
concentrations in the samples. 
Conclusion 
The present study was undertaken with an objective of developing 
simple, sensitive and reliable analytical method like UV-
Spectophotometry for estimation of OLM in tablet dosage form. 
The method has sufficiently good accuracy, precision and 
permitted as a cost effective as other methods. The analytical 
method is simple, sensitive, rapid and specific. Further it can be 
conveniently employed for the routine analysis and the quality 
control of OLM in tablet formulation. 
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Fig.1 Chemical structure of Olmesartan Medoxomil 
Sharma et al. International Journal of Drug Delivery 4 (1) 134-138 [2012] 
 
PAGE | 137 |
 
 
 
Fig 2 Calibration curve of Olmesartan medoxomil at 257nm 
 
 
Fig 3 Scan of Olmesartan medoxomil in distilled water 
 
 
Table 1  Optical characteristics and regression equation for OLM 
 
Parameter value 
Λ max (nm) 257 
Beer’s range (µg/ml) 2-14 
Regression equation Y= 0.0387x + 0.0921 
Intercept (a) 0.0921 
Slope(b) 0.0387 
Correlation co-efficient (r2) 0.9998 
Molar Absorptivity (lit/mole/cm) 2.8002×104 
Sandells sensitivity (µg/sq.cm/0.001 0.01995 
LOD(µg/ml) 0.1938 
LOQ(µg/ml) 0.6459 
 
Calibration curve of Olmesartan medoxomil at 257nm
y = 0.0387x + 0.0921
R2 = 0.9998
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Table 2 Assay of OLM tablet 20mg 
 
Formulation Label claim(mg) % Claim found % RSD 
F-I 20 99.8 0.112 
F-II 20 100.1 0.29 
* Mean of five observations 
 
Table 3 Results of Recovery study for Olmesartan medoxomil tablets 20mg 
 
Labeled 
amount (mg) 
Amount of 
drug added% 
Amount of drug 
recovered(mg) 
Percentage 
recovery 
%RSD 
20 80 36.01 100.05 0.06 
20 100 39.99 99.96 0.18 
20 120 44.02 100.1 0.20 
*Mean of three observations 
 
Table 4 Results of repeatability studies 
Label Claim(mg) Amount taken 
(µg/ml) 
Amount found % % RSD 
20 8 99.9±0.42 0.42 
* Mean of six observations 
 
Table -5 Intra –day and Inter-day precision 
Concentration(µg/ml) Intra-day %RSD Interday %RSD 
6 5.97± 0.02 0.31 5.87±0.03 0.41 
8 8.02± 0.07 0.62 8.01±0.09 0.80 
10 10.08±0.23 1.45 10.81±0.21 1.35 
* Mean of three observations 
 
Table -6 Results of Ruggedness study 
Label claim Analyst I 
Amount found % 
% RSD Analyst II 
Amount found % 
% RSD 
20mg 99.48±0.62 0.65 99.46±0.73 0.73 
 
 
 
